Notable Analyst Upgrades and Downgrades for Week of April 3 2023

 

 

Upgrades:

Allstate (NYSE:ALL) was upgraded by equities research analysts at William Blair from a “market perform” rating to an “outperform” rating in a research note issued to investors on Monday, The Fly reports.

ALL has been the topic of several other reports. Evercore ISI cut their price objective on shares of Allstate from $138.00 to $132.00 and set an “in-line” rating on the stock in a research report on Thursday, March 23rd. Barclays cut their price objective on shares of Allstate from $144.00 to $126.00 and set an “equal weight” rating on the stock in a research report on Friday, January 20th. BMO Capital Markets cut their price objective on shares of Allstate from $130.00 to $120.00 and set a “market perform” rating on the stock in a research report on Wednesday, March 29th. Piper Sandler boosted their price objective on shares of Allstate from $147.00 to $153.00 and gave the company an “overweight” rating in a research report on Tuesday, January 10th. Finally, Roth Capital reaffirmed a “buy” rating on shares of Allstate in a research report on Thursday, February 2nd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $146.08. Read more …

BNP Paribas upgraded shares of Chevron (NYSE:CVX) from an underperform rating to a neutral rating in a research report released on Tuesday morning, MarketBeat.com reports. The brokerage currently has $200.00 price objective on the oil and gas company’s stock.

A number of other equities analysts also recently weighed in on CVX. Morgan Stanley cut their price target on shares of Chevron from $195.00 to $192.00 and set an equal weight rating on the stock in a research note on Monday, March 27th. Wells Fargo & Company lowered their price target on shares of Chevron from $204.00 to $199.00 and set an overweight rating for the company in a report on Thursday, March 2nd. Cowen lowered their price target on shares of Chevron from $185.00 to $170.00 and set an outperform rating for the company in a report on Friday, February 24th. Barclays raised their price objective on shares of Chevron from $196.00 to $212.00 and gave the stock an overweight rating in a report on Tuesday, January 3rd. Finally, Mizuho reissued a neutral rating and set a $206.00 price objective on shares of Chevron in a report on Friday, March 17th. Eleven equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, Chevron has an average rating of Hold and an average target price of $189.89. Read more …

Prudential Financial (NYSE:PRU) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a research note issued to investors on Tuesday, The Fly reports.

A number of other equities analysts have also recently commented on PRU. StockNews.com began coverage on Prudential Financial in a research note on Thursday, March 16th. They issued a "hold" rating on the stock. Piper Sandler reiterated a "neutral" rating and set a $106.00 price target on shares of Prudential Financial in a report on Wednesday, February 8th. Royal Bank of Canada reissued a "sector perform" rating and issued a $110.00 price target on shares of Prudential Financial in a report on Thursday, February 9th. Wells Fargo & Company upped their price objective on shares of Prudential Financial from $97.00 to $100.00 and gave the company an "underweight" rating in a research note on Monday, February 13th. Finally, Morgan Stanley raised their target price on Prudential Financial from $112.00 to $114.00 and gave the stock an "equal weight" rating in a research note on Tuesday, January 10th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company. According to MarketBeat, Prudential Financial presently has an average rating of "Hold" and an average price target of $103.00. Read more ...

Morgan Stanley upgraded shares of CSX (NASDAQ:CSX) from an underweight rating to an equal weight rating in a research report sent to investors on Tuesday, Marketbeat.com reports. The firm currently has $24.00 price target on the transportation company’s stock.

CSX has been the subject of a number of other research reports. Wells Fargo & Company increased their target price on shares of CSX from $28.00 to $32.00 and gave the stock an equal weight rating in a research report on Wednesday, January 4th. Cowen raised their target price on CSX from $33.00 to $35.00 and gave the company a market perform rating in a research note on Thursday, January 26th. Susquehanna lifted their price objective on shares of CSX from $30.00 to $32.00 and gave the company a neutral rating in a research note on Thursday, January 26th. StockNews.com cut CSX from a buy rating to a hold rating in a research note on Sunday. Finally, Credit Suisse Group decreased their price objective on CSX from $38.00 to $37.00 and set an outperform rating for the company in a research report on Thursday, January 26th. Twelve analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of Hold and a consensus target price of $34.39. Read more …

Morgan Stanley upgraded shares of Norfolk Southern (NYSE:NSC) from an underweight rating to an equal weight rating in a report published on Tuesday, Marketbeat Ratings reports. The firm currently has $177.00 price objective on the railroad operator’s stock.

NSC has been the subject of several other research reports. Argus downgraded shares of Norfolk Southern from a buy rating to a hold rating in a research report on Wednesday, March 15th. Wolfe Research upgraded Norfolk Southern from a peer perform rating to an outperform rating and set a $255.00 price objective on the stock in a research note on Tuesday, February 21st. Bank of America decreased their price target on Norfolk Southern from $272.00 to $269.00 and set a buy rating on the stock in a research report on Tuesday, February 14th. JPMorgan Chase & Co. decreased their price objective on shares of Norfolk Southern from $236.00 to $232.00 and set a neutral rating on the stock in a research report on Thursday, January 26th. Finally, Susquehanna upped their target price on Norfolk Southern from $225.00 to $231.00 and gave the stock a neutral rating in a research note on Thursday, January 26th. Fifteen equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of Hold and a consensus target price of $249.83. Read more …

UnitedHealth Group (NYSE:UNH) was upgraded by equities research analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a research report issued on Wednesday, The Fly reports.

A number of other research firms also recently commented on UNH. UBS Group dropped their price objective on UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 18th. StockNews.com raised UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, March 29th. Loop Capital boosted their target price on UnitedHealth Group from $575.00 to $590.00 in a research report on Tuesday, January 17th. Stephens reaffirmed an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research report on Tuesday, February 28th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $615.00 to $617.00 and gave the stock a “buy” rating in a research report on Tuesday, January 24th. Three research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $601.61. Read more ...

Edward Jones upgraded shares of Accenture (NYSE:ACN) from a hold rating to a buy rating in a research report report published on Wednesday morning, MarketBeat Ratings reports.

Other equities research analysts have also recently issued reports about the company. Robert W. Baird reduced their price target on Accenture from $310.00 to $290.00 and set a neutral rating on the stock in a research note on Monday, December 19th. William Blair reissued an outperform rating on shares of Accenture in a research report on Monday, March 20th. Citigroup raised their target price on Accenture from $300.00 to $310.00 and gave the stock a buy rating in a research report on Friday, March 24th. JPMorgan Chase & Co. raised their target price on Accenture from $311.00 to $314.00 and gave the stock an overweight rating in a research report on Friday, March 24th. Finally, Piper Sandler cut Accenture from a neutral rating to an underweight rating and set a $268.00 price objective on the stock. in a research report on Monday, December 12th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of Hold and an average target price of $314.00. Read more …

Societe Generale upgraded shares of ConocoPhillips (NYSE:COP) from a sell rating to a hold rating in a research report report published on Wednesday, Marketbeat Ratings reports. Societe Generale currently has $105.00 price target on the energy producer’s stock.

COP has been the topic of a number of other reports. Wolfe Research cut ConocoPhillips from an outperform rating to a peer perform rating in a report on Thursday, January 12th. Morgan Stanley cut their price objective on ConocoPhillips from $122.00 to $115.00 and set an overweight rating for the company in a research report on Monday, March 27th. Mizuho cut their price objective on ConocoPhillips from $150.00 to $143.00 in a research report on Friday, March 10th. Capital One Financial lowered ConocoPhillips from an overweight rating to an equal weight rating and set a $102.00 price objective for the company. in a research report on Friday, February 3rd. Finally, Roth Capital restated a buy rating on shares of ConocoPhillips in a research report on Wednesday, February 1st. Five equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of Moderate Buy and an average price target of $135.19. Read more …

Welltower (NYSE:WELL) was upgraded by analysts at Citigroup from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, The Fly reports. The firm presently has a $81.00 target price on the real estate investment trust’s stock, up from their prior target price of $70.00. Citigroup’s target price suggests a potential upside of 13.21% from the stock’s current price.

Other analysts have also recently issued research reports about the company. Barclays lifted their price target on Welltower from $78.00 to $82.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 17th. Raymond James upgraded Welltower from an “outperform” rating to a “strong-buy” rating and upped their price target for the company from $72.00 to $82.00 in a research report on Monday, January 9th. Credit Suisse Group upped their price objective on Welltower from $72.00 to $80.00 and gave the company an “outperform” rating in a report on Monday. Finally, StockNews.com assumed coverage on Welltower in a research note on Thursday, March 16th. They set a “sell” rating on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $81.06. Read more …

Canadian National Railway (NYSE:CNI) (TSE:CNR) was upgraded by equities research analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating in a note issued to investors on Thursday, The Fly reports.

Other research analysts also recently issued research reports about the stock. StockNews.com began coverage on shares of Canadian National Railway in a research report on Thursday, March 16th. They set a "buy" rating for the company. Wells Fargo & Company dropped their price objective on shares of Canadian National Railway from $120.00 to $115.00 and set an "equal weight" rating for the company in a research note on Wednesday, January 25th. BMO Capital Markets dropped their price objective on shares of Canadian National Railway from C$185.00 to C$180.00 in a research note on Wednesday, January 25th. CIBC dropped their price objective on shares of Canadian National Railway from C$181.00 to C$175.00 in a research note on Wednesday, January 25th. Finally, Desjardins dropped their price objective on shares of Canadian National Railway from C$180.00 to C$179.00 in a research note on Wednesday, January 25th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $142.00. Read more …

Downgrades:

Automatic Data Processing (NASDAQ:ADP) was downgraded by equities researchers at Bank of America from a “neutral” rating to an “underperform” rating in a research note issued to investors on Monday, MarketBeat Ratings reports. They presently have a $211.00 target price on the business services provider’s stock, down from their previous target price of $249.00. Bank of America‘s price target suggests a potential downside of 1.42% from the stock’s current price.

ADP has been the subject of a number of other research reports. JPMorgan Chase & Co. dropped their price objective on shares of Automatic Data Processing from $253.00 to $245.00 and set an “underweight” rating for the company in a research note on Thursday, January 26th. Mizuho reduced their target price on shares of Automatic Data Processing from $285.00 to $275.00 and set a “buy” rating on the stock in a research note on Thursday, January 26th. Barclays dropped their target price on shares of Automatic Data Processing from $280.00 to $278.00 and set an “overweight” rating for the company in a research report on Sunday, January 29th. Citigroup reduced their price target on shares of Automatic Data Processing from $260.00 to $235.00 in a research report on Friday, March 31st. Finally, Wolfe Research raised their price objective on shares of Automatic Data Processing from $220.00 to $225.00 in a report on Thursday, January 5th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $243.36. Read more …

Bank of America cut shares of Paychex (NASDAQ:PAYX) from a neutral rating to an underperform rating in a report released on Monday morning, MarketBeat.com reports. Bank of America currently has $105.00 target price on the business services provider’s stock, down from their previous target price of $119.00.

Other equities research analysts have also issued research reports about the stock. Jefferies Financial Group cut their price target on shares of Paychex from $130.00 to $120.00 and set a hold rating on the stock in a report on Thursday, December 22nd. Barclays cut their target price on shares of Paychex from $110.00 to $105.00 and set an underweight rating on the stock in a research note on Monday, March 13th. Citigroup cut their target price on shares of Paychex from $131.00 to $119.00 in a research note on Friday, December 23rd. Morgan Stanley lowered their price target on shares of Paychex from $130.00 to $125.00 and set an equal weight rating for the company in a research report on Friday, December 23rd. Finally, Evercore ISI lowered their price target on shares of Paychex from $117.00 to $114.00 in a research report on Tuesday, December 27th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of Hold and a consensus target price of $122.79. Read more …

CubeSmart (NYSE:CUBE) was downgraded by Raymond James from a “strong-buy” rating to an “outperform” rating in a report issued on Tuesday, The Fly reports.

Several other research firms have also recently weighed in on CUBE. Wolfe Research initiated coverage on CubeSmart in a report on Tuesday, January 17th. They set an “outperform” rating and a $48.00 price target for the company. Truist Financial lifted their target price on CubeSmart from $46.00 to $47.00 and gave the stock a “hold” rating in a report on Wednesday, March 8th. StockNews.com initiated coverage on shares of CubeSmart in a research note on Thursday, March 16th. They issued a “hold” rating on the stock. Finally, Jefferies Financial Group lowered shares of CubeSmart from a “buy” rating to a “hold” rating and lowered their price target for the stock from $47.00 to $41.00 in a research report on Monday, January 2nd. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $48.57. Read more …

Albemarle (NYSE:ALB) was downgraded by research analysts at Bank of America from a “neutral” rating to an “underperform” rating in a research report issued on Wednesday, The Fly reports.

Other analysts also recently issued reports about the company. StockNews.com started coverage on Albemarle in a research note on Thursday, March 16th. They set a “hold” rating for the company. CICC Research assumed coverage on Albemarle in a research note on Tuesday, February 21st. They set a “market perform” rating for the company. Royal Bank of Canada increased their target price on Albemarle from $340.00 to $362.00 in a research note on Wednesday, January 25th. Citigroup cut their target price on Albemarle from $345.00 to $295.00 and set a “buy” rating for the company in a research note on Thursday, December 15th. Finally, Oppenheimer increased their target price on Albemarle from $497.00 to $498.00 and gave the stock an “outperform” rating in a research note on Friday, February 17th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, Albemarle presently has an average rating of “Hold” and an average target price of $308.00. Read more …

Argus cut shares of AbbVie (NYSE:ABBV) from a buy rating to a hold rating in a report published on Wednesday, MarketBeat reports.

ABBV has been the topic of several other research reports. Piper Jaffray Companies raised their price objective on shares of AbbVie from $157.00 to $163.00 and gave the stock an overweight rating in a research note on Friday, February 10th. Atlantic Securities cut their price target on AbbVie from $157.00 to $154.00 and set a neutral rating for the company in a report on Friday, February 10th. Guggenheim assumed coverage on AbbVie in a report on Tuesday, February 28th. They set a buy rating and a $172.00 price objective for the company. Morgan Stanley decreased their target price on AbbVie from $182.00 to $178.00 and set an overweight rating for the company in a research report on Friday, February 10th. Finally, Wolfe Research lowered AbbVie from an outperform rating to a peer perform rating in a research report on Wednesday, February 22nd. They noted that the move was a valuation call. Ten analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of Hold and an average price target of $161.12. Read more …

Archive of Upgrades and Downgrades